Tci Wealth Advisors, Inc. Sio Gene Therapies Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$0.28 - $0.41 $84 - $122	-300 Reduced 42.86%	400 $0
Q1 2022 Apr 29, 2022	BUY	$0.55 - $1.47 $385 - $1,029	700 New	700 $0
Q4 2021 Jan 24, 2022	SELL	$1.29 - $2.36 $1,806 - $3,304	-1,400 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$1.81 - $2.7 $2,534 - $3,780	1,400 New	1,400 $3,000
Q2 2021 Aug 02, 2021	SELL	$2.07 - $2.89 $5,175 - $7,225	-2,500 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$2.34 - $3.44 $234 - $344	-100 Reduced 3.85%	2,500 $7,000
Q4 2020 Jan 21, 2021	BUY	$1.91 - $5.63 $4,966 - $14,638	2,600 New	2,600 $7,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.